What is it about?
We have tested a new chemical compound in mice. The changes in behaviour seen in the mice suggest that this new compound could be a useful antidepressant. Importantly, this new compound targets a different brain pathway to existing antidepressant treatments - the opioid system.
Featured Image
Read the Original
This page is a summary of: Antidepressant‐like effects of BU10119, a novel buprenorphine analogue with mixed κ/μ receptor antagonist properties, in mice, British Journal of Pharmacology, November 2017, Wiley,
DOI: 10.1111/bph.14060.
You can read the full text:
Contributors
The following have contributed to this page